Jean Francois Formela, Director at Intellia Therapeutics, Inc. (NTLA), sold 78,490 shares at $25.06 ($1.9M) on 2018-03-20, disclosed to the SEC on 2018-03-22.
Open-market sale of $1.9M NTLA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.78 | 36,628 | $871K | 46.5% |
| 2 | $23.78 | 36,628 | $871K | 46.5% |
| 3 | $25.06 | 2,617 | $66K | 3.5% |
| 4 | $25.06 | 2,617 | $66K | 3.5% |
| Total | $23.87 avg | 78,490 | $1.9M | 100% |
| Filing → |
| KRRO | SELL | 2026-08-21 | $399K | — | Filing → |
| KRRO | SELL | 2026-08-13 | $30K | — | Filing → |
| KRRO | SELL | 2026-07-07 | $1.5M | — | Filing → |